ReviewScience advances2023
Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients.
Suman Nag et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled itcites it